Before you continue
By clicking “Accept All”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Dr. Khaldoun Taha

Dr. Khaldoun Taha

Consultant Cardiology
English and Arabic
25 years

Core Competencies

  • Special interest in heart failure  ,Hypertensive Heart disease and Management of coronary artery disease  

Brief Profile

Dr. Khaldoun has had an outstanding career till date. He has been awarded the Resident of the Year, Cook County Hospital, Chicago, Illinois (1988) and the Physician’s Recognition Award, American Medical Association (1994).

He has also been affiliated with numerous associations, like:

  • Fellow American College of Cardiology (1997
  • Member of American Heart Association (2007)
  • Member of American College of Physicians (1995)
  • Fellow American College of International Physicians (1989)


Dr. Khaldoun Taha has undertaken his studies from the University of Illinois- Chicago, Illinois Post Graduate Work Public Health Program (1983-1984), and Faculty of Medicine-University of Aleppo, Aleppo, Syria-Doctor of Medicine (September 1976-August 1982).

He has had his licensure and certifications from these organizations:

  • (MOC) American Board of Internal Medicine, Cardiovascular Diseases (2016-2025)
  • (MOC) American Board of Internal Medicine, Cardiovascular Diseases (1995 Re-certified 2006)
  • American Board of Internal Medicine (1988)
  • DHA, Dubai (1996-current)
  • State of West Virginia (1994)  
  • State of Missouri (1991)
  • State of Illinois (1985)

Research & Publications

Dr. Khaldoun has numerous publications and research documents in his name. Some of them are:

  • Khaldoun Sayed- Taha, M.D., Principle Investigator: i- SEARCH, International Survey Evaluating Microalbuminuria Routinely by Cardiologist in patients with Hypertension (2005)    
  • Khaldoun Sayed- Taha, M.D., Principle Investigator: Crestor, Discovery Alpha Study (January 2005)                  
  • Role of RAAS Inhibition in Managing the Post- MI Patients: Insights from the VALIANT Trial, Istanbul, Turkey
  • New Modality for the Treatment of Hypertension, Dubai U.A.E
  • Coronary artery disease, Clinical Approach and Therapy, Marshall University School of Medicine Cardiology Symposium, Huntington West Virginia
  • James H. O’Keefe Jr. M.D, Khaldoun Sayed- Taha, M.D., Wayne Gibson, M.D., Timothy F. Christian, Timothy M. Bateman, Raymond Gibbons, M.D. “Do Patients with left Circumflex Coronary Artery- Related Acute Myocardial Infarctions Without ST-Segment Elevators Benefit from Reperfusion   Therapy Am J Cardio 1995; 75: 718-720
  • Sayed- Taha, K. Krikorian, Brisnahan, Ligon Bateman, McAllister, Hartzler, O’Keefe: Beta Blockers with Direct Infarc Angioplasty Liability or Useful Adjuncts. JACC 21, (2): 77 A